- Report
- October 2023
- 162 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- October 2023
- 161 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- July 2023
- 156 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2023
- 158 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- May 2023
- 157 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- March 2023
- 162 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- September 2022
- 120 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- August 2022
- 120 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2022
- 120 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- June 2022
- 120 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- March 2022
- 120 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- July 2021
- 120 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- October 2023
- 190 Pages
Global
From €2764EUR$2,799USD£2,300GBP
- Report
- September 2023
- 140 Pages
Global
From €2962EUR$2,999USD£2,464GBP
- Report
- July 2023
- 140 Pages
Global
From €5925EUR$5,999USD£4,930GBP
- Report
- May 2023
- 140 Pages
Global
From €5925EUR$5,999USD£4,930GBP
- Report
- May 2023
- 160 Pages
Global
From €5925EUR$5,999USD£4,930GBP
- Report
- May 2023
- 160 Pages
Global
From €5925EUR$5,999USD£4,930GBP
- Report
- May 2023
- 140 Pages
Global
From €5925EUR$5,999USD£4,930GBP
- Report
- May 2023
- 140 Pages
Global
From €5925EUR$5,999USD£4,930GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more